Literature DB >> 24752771

No association of pri-miR-143 rs41291957 polymorphism with the risk of congenital heart disease in a Chinese population.

Liping Yang1, Xiaobo Gao, Haiyan Luo, Qiuyu Huang, Ying Wei, Guican Zhang, Guoying Huang, Dongmei Su, Liangwan Chen, Cailing Lu, Juhua Yang, Xu Ma.   

Abstract

MiR-143 plays an important role in the heart development of zebra fish. The rs41291957 variant located in the pri-miR-143 sequence is associated with colorectal carcinogenesis. Therefore, the authors hypothesized that rs41291957 in pri-miR-143 might be involved in the risk of sporadic congenital heart disease (CHD). The authors conducted a case-control study of CHD in a Chinese population to test their hypothesis by genotyping pri-miR-143 rs41291957 in 1,109 CHD cases and 915 non-CHD control subjects. Logistic regression analyses showed no significant association of genotype or allele frequencies of pri-miR-143 rs41291957 A/G polymorphism with the CHD cases in overall or various subtypes compared with the control group. To the authors' knowledge, this is the first study to investigate the relationship between miR-143 and CHD cases. The results demonstrated that rs41291957 in pri-miR-143 has no major role in genetic susceptibility to sporadic CHD, at least in the current study population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752771     DOI: 10.1007/s00246-014-0898-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  25 in total

1.  Heartbeat regulates cardiogenesis by suppressing retinoic acid signaling via expression of miR-143.

Authors:  Kota Y Miyasaka; Yasuyuki S Kida; Toshihiro Banjo; Yosuke Ueki; Kazuaki Nagayama; Takeo Matsumoto; Masaaki Sato; Toshihiko Ogura
Journal:  Mech Dev       Date:  2010-09-30       Impact factor: 1.882

Review 2.  Genetic mechanisms controlling cardiovascular development.

Authors:  Jamie Bentham; Shoumo Bhattacharya
Journal:  Ann N Y Acad Sci       Date:  2008-03       Impact factor: 5.691

3.  Whole genome expression differences in human left and right atria ascertained by RNA sequencing.

Authors:  Jeffrey Hsu; Peter Hanna; David R Van Wagoner; John Barnard; David Serre; Mina K Chung; Jonathan D Smith
Journal:  Circ Cardiovasc Genet       Date:  2012-04-03

Review 4.  MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease.

Authors:  W H Davin Townley-Tilson; Thomas E Callis; DaZhi Wang
Journal:  Int J Biochem Cell Biol       Date:  2009-03-14       Impact factor: 5.085

Review 5.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

6.  Genomic analysis of human microRNA transcripts.

Authors:  Harpreet Kaur Saini; Sam Griffiths-Jones; Anton James Enright
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

7.  MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.

Authors:  Deyao Wu; Ping Huang; Linmao Wang; Yunfeng Zhou; Huixing Pan; Ping Qu
Journal:  Mol Med Rep       Date:  2013-05-31       Impact factor: 2.952

8.  MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer.

Authors:  Yu Zhang; Zhongqiu Wang; Min Chen; Liang Peng; Xinying Wang; Qunying Ma; Fengli Ma; Bo Jiang
Journal:  Mol Cancer       Date:  2012-04-25       Impact factor: 27.401

Review 9.  Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.

Authors:  Ondrej Slaby; Julie Bienertova-Vasku; Marek Svoboda; Rostislav Vyzula
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  2 in total

1.  APRISMA-compliant systematic review and meta-analysis determining the association of miRNA polymorphisms and risk of congenital heart disease.

Authors:  Xing-Yan Li; Kun Chen; Zheng-Tao Lv
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

2.  rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk.

Authors:  Ignacio Fernando Hall; Montserrat Climent; Chiara Viviani Anselmi; Laura Papa; Vinicius Tragante; Luca Lambroia; Floriana Maria Farina; Marcus E Kleber; Winfried März; Carlo Biguori; Gianluigi Condorelli; Leonardo Elia
Journal:  EMBO Mol Med       Date:  2021-09-22       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.